Rocket


News + Filings
Holdings


All
13F
13D/G
Other

Decheng Capital Management III (Cayman), LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
07/28/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/10/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/09/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/08/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
09/27/2022 4 Decheng Capital China Life Sciences USD Fund III, L.P. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns: Granted 639,456 shares @ $7.35, valued at $4.7M
Granted 1,360,544 shares @ $7.35, valued at $10M
08/01/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/10/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2022 SC 13G Decheng Capital Management III , LLC reports a 15.1% stake in Equillium Inc.
02/14/2022 SC 13G Decheng Capital Management III , LLC reports a 6.2% stake in Checkmate Pharamaceuticals, Inc.
02/14/2022 SC 13G Decheng Capital Management III , LLC reports a 12.7% stake in BeyondSpring Inc.
02/14/2022 SC 13G Decheng Capital Management III , LLC reports a 16.1% stake in Alpine Immune Sciences, Inc.
02/14/2022 SC 13G Decheng Capital Management III , LLC reports a 6.1% stake in Cue Health Inc.
09/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/23/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
09/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/23/2019 3 Decheng Capital China Life Sciences USD Fund III, L.P. (10% Owner) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy